ImmunoScape develops T cell receptor (TCR)-based therapeutics for solid tumors by utilizing deep immunomics and machine learning to identify and characterize novel TCRs. The platform addresses the need for effective cancer treatments by generating a diverse portfolio of TCRs aimed at enhancing immune response against tumor cells.
Funding
$51.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Solid tumors often evade the immune system, requiring novel therapeutic approaches to enhance T cell recognition and response. Current cancer treatments may lack the specificity needed to target tumor cells effectively, leading to off-target effects and limited efficacy. The discovery and development of T cell receptor (TCR)-based therapies are hindered by the complexity of identifying and characterizing relevant TCRs that can effectively target solid tumors.
Solution
ImmunoScape leverages its Deep Immunomics and Machine Learning platforms to discover and develop a diverse portfolio of novel TCRs against solid tumors. By identifying unique TCR hits, ImmunoScape aims to create highly effective and differentiated T cell receptor-based therapeutics. The company's multi-pronged approach, combined with novel tumor targets, seeks to enhance immune response against tumor cells. ImmunoScape is focused on advancing its assets towards clinical candidate nomination, with a pipeline consisting of different cell therapy programs targeting solid tumors.
Target Audience
The primary target audience includes oncology researchers and clinicians focused on developing novel immunotherapies for solid tumors.
Features
- Deep Immunomics platform for comprehensive TCR repertoire analysis
- Machine Learning algorithms to identify and characterize novel TCRs
- Discovery engine continuously generating unique TCR hits
- Pipeline of TCR-based therapeutics targeting solid tumors
- Focus on developing cell therapy programs